Abridge acquihired/acquired Altrina, a YC-backed agentic workflow-automation startup; terms were not disclosed. The deal adds browser/computer-use workflow automation talent and technology.
SourceAI-powered clinical documentation for healthcare.
Public company, workplace, funding, and market signals
Updated Jul 28, 2026
Abridge AI, Inc. is a private healthcare-AI company founded in 2018. Its purpose-built generative-AI platform turns patient-clinician conversations and surrounding clinical context into auditable clinical intelligence, reducing documentation burden and extending into nursing, revenue-cycle, clinical-decision-support, payer, and life-sciences workflows. Abridge reports more than 300 health-system deployments and over 100 million annual conversations as of June 2026. [Abridge About; Abridge June 2026 release]
Primary product
Abridge’s enterprise clinician-intelligence platform: ambient capture and structured clinical documentation, with pre-visit context, in-visit decision support, post-visit notes/orders/codes, nursing documentation, revenue-cycle/CDI, and evidence-grounded Clinical Decision Support.
Founded
2018
Headquarters
San Francisco, California, United States
Team size
Approximately 400–500; one third-party estimate lists 451 employees in 2026.
Work style
43 jobs at Abridge
Hybrid
Industry
Artificial intelligence
Sub-industry
Healthcare AI; ambient clinical documentation and clinician intelligence
Offices
Business model
Stage
Series E / late-stage private company; also received a later undisclosed strategic Eli Lilly investment
Total raised
$830M
Latest round
Strategic corporate investment / Corporate Minority - II (Eli Lilly) · Jun 2026
Jun 2025 · Andreessen Horowitz (a16z)
Feb 2025 · Elad Gil and IVP
Feb 2024 · Lightspeed Venture Partners
Oct 2023 · Spark Capital
Aug 2022 · Wittington Ventures
Seed + Series A (combined disclosed at launch)
Oct 2020 · Union Square Ventures and UPMC
Leadership
CEO and Co-Founder
San Oo
Chief Technology Officer
Chief Operating Officer
Chief Commercial Officer
Chief Financial Officer
General Counsel
Founders
Florian Metze
Co-Founder
Sandeep Konam
Co-Founder
Founder and CEO
Co-Founder, CTO and Chief Scientific Officer
Mission-driven, clinically oriented builder culture combining practicing physicians, AI scientists, PhDs, engineers, and designers. Abridge emphasizes co-location and collaboration for builder teams at its San Francisco and New York hubs, autonomy, continuous improvement, a blameless culture, and values including action, helping others win, and honoring humanity.
Work style
Hybrid
Compensation
Public job postings commonly show base-salary ranges plus equity; some commercial roles include bonus or commission. Example engineering postings show roughly $157K–$313K base ranges depending on level/location, while senior technical roles commonly list approximately $210K–$325K plus equity. Visa policy is not clearly stated publicly.
Benefits
Pricing
Enterprise contract / sales-led pricing; no public price list, self-serve tier, or public free trial found.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately $40M–$50M based on a third-party company estimate; another database reports $117M for 2025. Treat as low-confidence private-company estimates, not audited revenue.
Estimated monthly visits
158.6K
Abridge acquihired/acquired Altrina, a YC-backed agentic workflow-automation startup; terms were not disclosed. The deal adds browser/computer-use workflow automation talent and technology.
SourceBusiness Insider reported strategic tension and execution risk around Abridge’s dependence on Epic’s ecosystem while Epic develops competing AI capabilities. This is a competitive/ecosystem risk, not a reported shutdown or layoff.
SourceTechTarget · Jul 2026
Abridge acquired/acquihired Altrina, bringing in browser and computer-use agent expertise for multi-system healthcare workflow automation; terms were undisclosed.
Abridge · Jun 2026
Abridge announced a broader platform spanning pre-visit preparation, in-visit support, documentation, orders, codes, nursing, payment alignment, evidence-based care, and integrations with Epic, Oracle Health, and athenahealth; it also announced NVIDIA collaboration and Northwestern Medicine’s enterprise rollout.
STAT · Jun 2026
STAT reported Abridge’s NVIDIA foundation-model collaboration and Lilly strategic investment as the company broadens beyond ambient notes.
Fierce Healthcare · Jun 2026
Eli Lilly made an undisclosed strategic investment to support evidence-based care and clinical-trial workflows; Abridge also described expansion into billing, prior authorization, payer, and life-sciences use cases.
Reuters · Jun 2025
Abridge raised $300M in Series E led by Andreessen Horowitz with Khosla Ventures participating, reaching a reported $5.3B valuation after a $250M raise earlier in 2025.